312 related articles for article (PubMed ID: 36100986)
1. Nanocarriers Based Ocular Therapeutics: Updates, Challenges and Future Prospectives.
Kaushal U; Kaur M; Nagpal M; Bhuyan M; Gounder KP
Curr Drug Res Rev; 2023; 15(1):15-28. PubMed ID: 36100986
[TBL] [Abstract][Full Text] [Related]
2. Nanocarriers for ocular drug delivery: current status and translational opportunity.
Gorantla S; Rapalli VK; Waghule T; Singh PP; Dubey SK; Saha RN; Singhvi G
RSC Adv; 2020 Jul; 10(46):27835-27855. PubMed ID: 35516960
[TBL] [Abstract][Full Text] [Related]
3. Fostering the unleashing potential of nanocarriers-mediated delivery of ocular therapeutics.
Datta D; Priyanka Bandi S; Colaco V; Dhas N; Siva Reddy DV; Vora LK
Int J Pharm; 2024 Jun; 658():124192. PubMed ID: 38703931
[TBL] [Abstract][Full Text] [Related]
4. Overview of Recent Advances in Nano-Based Ocular Drug Delivery.
Liu LC; Chen YH; Lu DW
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895032
[TBL] [Abstract][Full Text] [Related]
5. Applications of Nanotechnology-mediated Herbal Nanosystems for Ophthalmic Drug.
Shree D; Patra CN; Sahoo BM
Pharm Nanotechnol; 2024; 12(3):229-250. PubMed ID: 37587812
[TBL] [Abstract][Full Text] [Related]
6. Advancements in Nanosystems for Ocular Drug Delivery: A Focus on Pediatric Retinoblastoma.
Wu KY; Wang XC; Anderson M; Tran SD
Molecules; 2024 May; 29(10):. PubMed ID: 38792122
[TBL] [Abstract][Full Text] [Related]
7. Ocular drug delivery systems: An overview.
Patel A; Cholkar K; Agrahari V; Mitra AK
World J Pharmacol; 2013; 2(2):47-64. PubMed ID: 25590022
[TBL] [Abstract][Full Text] [Related]
8. Ocular Drug Delivery: Present Innovations and Future Challenges.
Gote V; Sikder S; Sicotte J; Pal D
J Pharmacol Exp Ther; 2019 Sep; 370(3):602-624. PubMed ID: 31072813
[TBL] [Abstract][Full Text] [Related]
9. Nanotechnology in ocular drug delivery.
Sahoo SK; Dilnawaz F; Krishnakumar S
Drug Discov Today; 2008 Feb; 13(3-4):144-51. PubMed ID: 18275912
[TBL] [Abstract][Full Text] [Related]
10. A review of nanocarrier-mediated drug delivery systems for posterior segment eye disease: challenges analysis and recent advances.
Wang R; Gao Y; Liu A; Zhai G
J Drug Target; 2021 Aug; 29(7):687-702. PubMed ID: 33474998
[TBL] [Abstract][Full Text] [Related]
11. A Mini-review on New Developments in Nanocarriers and Polymers for Ophthalmic Drug Delivery Strategies.
Sharma Y; Patel P; Kurmi BD
Curr Drug Deliv; 2024; 21(4):488-508. PubMed ID: 37143264
[TBL] [Abstract][Full Text] [Related]
12. Ocular drug delivery.
Gaudana R; Ananthula HK; Parenky A; Mitra AK
AAPS J; 2010 Sep; 12(3):348-60. PubMed ID: 20437123
[TBL] [Abstract][Full Text] [Related]
13. Recent advance of nanoparticle-based topical drug delivery to the posterior segment of the eye.
Wang Y; Xu X; Gu Y; Cheng Y; Cao F
Expert Opin Drug Deliv; 2018 Jul; 15(7):687-701. PubMed ID: 29985660
[TBL] [Abstract][Full Text] [Related]
14. Delivery of therapeutics for deep-seated ocular conditions - status quo.
Nguyen H; Eng S; Ngo T; Dass CR
J Pharm Pharmacol; 2018 Aug; 70(8):994-1001. PubMed ID: 29675844
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in topical ophthalmic drug delivery with lipid-based nanocarriers.
Gan L; Wang J; Jiang M; Bartlett H; Ouyang D; Eperjesi F; Liu J; Gan Y
Drug Discov Today; 2013 Mar; 18(5-6):290-7. PubMed ID: 23092895
[TBL] [Abstract][Full Text] [Related]
16. Colloidal drug delivery system: amplify the ocular delivery.
Ali J; Fazil M; Qumbar M; Khan N; Ali A
Drug Deliv; 2016; 23(3):710-26. PubMed ID: 24892625
[TBL] [Abstract][Full Text] [Related]
17. Drug delivery to the eye: what benefits do nanocarriers offer?
Joseph RR; Venkatraman SS
Nanomedicine (Lond); 2017 Mar; 12(6):683-702. PubMed ID: 28186436
[TBL] [Abstract][Full Text] [Related]
18. Ocular Drug Delivery: Role of Degradable Polymeric Nanocarriers for Ophthalmic Application.
Tsai CH; Wang PY; Lin IC; Huang H; Liu GS; Tseng CL
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30235809
[TBL] [Abstract][Full Text] [Related]
19. Niosomal Drug Delivery Systems for Ocular Disease-Recent Advances and Future Prospects.
Durak S; Esmaeili Rad M; Alp Yetisgin A; Eda Sutova H; Kutlu O; Cetinel S; Zarrabi A
Nanomaterials (Basel); 2020 Jun; 10(6):. PubMed ID: 32570885
[TBL] [Abstract][Full Text] [Related]
20. Nanocarriers in ocular drug delivery: an update review.
Wadhwa S; Paliwal R; Paliwal SR; Vyas SP
Curr Pharm Des; 2009; 15(23):2724-50. PubMed ID: 19689343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
